These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15558944)

  • 21. Mechanism of inactivation of γ-aminobutyric acid aminotransferase by (1S,3S)-3-amino-4-difluoromethylene-1-cyclopentanoic acid (CPP-115).
    Lee H; Doud EH; Wu R; Sanishvili R; Juncosa JI; Liu D; Kelleher NL; Silverman RB
    J Am Chem Soc; 2015 Feb; 137(7):2628-40. PubMed ID: 25616005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active site model for gamma-aminobutyrate aminotransferase explains substrate specificity and inhibitor reactivities.
    Toney MD; Pascarella S; De Biase D
    Protein Sci; 1995 Nov; 4(11):2366-74. PubMed ID: 8563634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and biological activity of a difluoro-substituted, conformationally rigid vigabatrin analogue as a potent gamma-aminobutyric acid aminotransferase inhibitor.
    Pan Y; Qiu J; Silverman RB
    J Med Chem; 2003 Dec; 46(25):5292-3. PubMed ID: 14640537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACS chemical neuroscience molecule spotlight on Sabril.
    Hopkins CR
    ACS Chem Neurosci; 2010 Jul; 1(7):475. PubMed ID: 22778839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental studies of the influence of vigabatrin on the GABA system.
    Gram L; Larsson OM; Johnsen A; Schousboe A
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):13S-17S. PubMed ID: 2757904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of GABA-transaminase inhibitor Vigabatrin on thermoregulation in rats.
    Nikolov RP; Yakimova KS
    Amino Acids; 2011 May; 40(5):1441-5. PubMed ID: 20878340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of Inactivation of GABA Aminotransferase by (E)- and (Z)-(1S,3S)-3-Amino-4-fluoromethylenyl-1-cyclopentanoic Acid.
    Lee H; Le HV; Wu R; Doud E; Sanishvili R; Kellie JF; Compton PD; Pachaiyappan B; Liu D; Kelleher NL; Silverman RB
    ACS Chem Biol; 2015 Sep; 10(9):2087-98. PubMed ID: 26110556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective Targeting by a Mechanism-Based Inactivator against Pyridoxal 5'-Phosphate-Dependent Enzymes: Mechanisms of Inactivation and Alternative Turnover.
    Mascarenhas R; Le HV; Clevenger KD; Lehrer HJ; Ringe D; Kelleher NL; Silverman RB; Liu D
    Biochemistry; 2017 Sep; 56(37):4951-4961. PubMed ID: 28816437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanistic crystallography. Mechanism of inactivation of gamma-aminobutyric acid aminotransferase by (1R,3S,4S)-3-amino-4-fluorocyclopentane-1-carboxylic acid as elucidated by crystallography.
    Storici P; Qiu J; Schirmer T; Silverman RB
    Biochemistry; 2004 Nov; 43(44):14057-63. PubMed ID: 15518554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structure of GABA-aminotransferase, a target for antiepileptic drug therapy.
    Storici P; Capitani G; De Biase D; Moser M; John RA; Jansonius JN; Schirmer T
    Biochemistry; 1999 Jul; 38(27):8628-34. PubMed ID: 10393538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers.
    Zwanzger P; Baghai TC; Schuele C; Ströhle A; Padberg F; Kathmann N; Schwarz M; Möller HJ; Rupprecht R
    Neuropsychopharmacology; 2001 Nov; 25(5):699-703. PubMed ID: 11682253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of vigabatrin on contractile response to arachidonic acid and prostaglandins in smooth muscle preparations and platelet aggregation in experimental laboratory animals.
    Raza M; Al-Shabanah OA
    Pharmacol Res; 2003 Jun; 47(6):477-83. PubMed ID: 12742000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the enzyme, GABA-aminotransferase in human platelets by vigabatrin, a potential antiepileptic drug.
    Rimmer E; Kongola G; Richens A
    Br J Clin Pharmacol; 1988 Feb; 25(2):251-9. PubMed ID: 3358887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of novel aromatic substrates and competitive inhibitors of GABA aminotransferase.
    Clift MD; Silverman RB
    Bioorg Med Chem Lett; 2008 May; 18(10):3122-5. PubMed ID: 17988865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (+/-)-(1S,2R,5S)-5-Amino-2-fluorocyclohex-3-enecarboxylic acid. A potent GABA aminotransferase inactivator that irreversibly inhibits via an elimination-aromatization pathway.
    Wang Z; Yuan H; Nikolic D; Van Breemen RB; Silverman RB
    Biochemistry; 2006 Dec; 45(48):14513-22. PubMed ID: 17128990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the GABA-transaminase inhibitor vigabatrin on exploratory behaviour in socially isolated rats.
    Sherif F; Oreland L
    Behav Brain Res; 1995 Dec; 72(1-2):135-40. PubMed ID: 8788866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology of vigabatrin.
    Sabers A; Gram L
    Pharmacol Toxicol; 1992 Apr; 70(4):237-43. PubMed ID: 1608908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4-Amino-2-(substituted methyl)-2-butenoic acids: substrates and potent inhibitors of gamma-aminobutyric acid aminotransferase.
    Silverman RB; Durkee SC; Invergo BJ
    J Med Chem; 1986 May; 29(5):764-70. PubMed ID: 3701787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visual electrophysiological effect of a GABA transaminase blocker.
    Harding GF; Robertson KA; Edson AS; Barnes P; Wild J
    Doc Ophthalmol; 1998-1999; 97(2):179-88. PubMed ID: 10765970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and evaluation of newer 5,6-dihydropyrimidine-2(1H)-thiones as GABA-AT inhibitors for anticonvulsant potential.
    Sahu M; Siddiqui N; Iqbal R; Sharma V; Wakode S
    Bioorg Chem; 2017 Oct; 74():166-178. PubMed ID: 28806600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.